In MM, there are several inhibitory mechanisms: Treg- and TAM-derived TGF-β, PGE2, or IL-15/IL-15R axis inhibition via BM stroma cells, and HLA-E expression on MM cells impair NK cell function [81]. The gene discussed is HLA-E; the disease is Miyoshi myopathy.